Nicholas Conrad Smith
CFO, President at Alto Neuroscience, Inc. (ANRO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 1SEC | ANROAlto Neuroscience, Inc. | Sell Plan | 110,83024,060 held (−82%) | $26.58 | $2.9M | -17.5% |
| Oct 1SEC | ANROAlto Neuroscience, Inc. | Sell Plan | 23,17024,946 held (−48%) | $25.78 | $597K | -14.9% |
| Oct 1SEC | ANROAlto Neuroscience, Inc. | Sell Plan | 88624,060 held (−4%) | $26.87 | $24K | -18.3% |
- Sell
CFO, President Nicholas Conrad Smith sold $2.9M of ANRO at $26.58 — cuts the stake by 82%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Nicholas Conrad Smith sold $597K of ANRO at $25.78 — cuts the stake by 48%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Nicholas Conrad Smith sold $24K of ANRO at $26.87 — pre-scheduled 10b5-1 plan sale.